Bixiye
P7-21 Change in Liability for Members of Other Blue Plans
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2021
Natiijooyinka Raadinta
Soo bandhiga 1751 - 1760 ee natiijooyinka 4296
Bixiye
QP5-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Sucraid® (sacrosidase) PAQL
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Bixiye
QP7-21 Replacement Claim Submission Guidelines
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Bixiye
QP6-21 MHCP Pharmacy Benefit Exclusion for OxlumoTM and Danyelza®
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Bixiye
QP8-21 Change in Suspect COVID-19 Diagnosis Code
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Bixiye
QP4-21 Commercial Pharmacy Benefit Exclusion for OxlumoTM
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2021
Bixiye
QP1-21 Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective March 1, 2021
Taariikhda uu dhaqangalayo Barnaamijka: Jan 13, 2021
Bixiye
QP3-21 Commercial and MHCP Pharmacy Benefit Exclusion for Barhemsys® and Monoferric®
Taariikhda uu dhaqangalayo Barnaamijka: Jan 13, 2021